Table 2.
Peak Response, % |
Cumulative Response, % |
||||
---|---|---|---|---|---|
Study | Parameter | Vehicle | Drug | Vehicle | Drug |
Naloxone | Frequency, breaths/min | +4 ± 4 | +71 ± 19*,† | −2 ± 2 | +36 ± 6*,† |
Tidal Volume, mls | −9 ± 9 | +1 ± 4 | −2 ± 1 | −15 ± 3*,† | |
Minute Ventilation, mls/min | +6 ± 8 | +52 ± 11*,† | −4 ± 2 | +15 ± 4*,† | |
Naltrindole | Frequency, breaths/min | +52 ± 8* | +77 ± 13* | +7 ± 3 | +39 ± 4*,† |
Tidal Volume, mls | −16 ± 3* | −15 ± 3* | +3 ± 1 | −8 ± 2*,† | |
Minute Ventilation, mls/min | +24 ± 3* | +54 ± 7*,† | +9 ± 2* | +20 ± 2*,† | |
D-penicillamine | Frequency, breaths/min | +10 ± 6 | +48 ± 6 | +3 ± 4 | +17 ± 4*,† |
Tidal Volume, mls | +1 ± 3 | +6 ± 4 | +1 ± 3 | +1 ± 4 | |
Minute Ventilation, mls/min | +6 ± 4 | +43 ± 7*,† | +3 ± 2 | +18 ± 5*,† |
The data are presented as mean ± SEM. There were six rats in each group.
P < 0.05, significant response.
P < 0.05, drug-treated versus vehicle-treated rats.